The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit atherogenic events: A study of the combination effects of the 2-herb formula

被引:42
作者
Cheung, David Wing-Shing [1 ,2 ]
Koon, Chi-Man [1 ,2 ]
Ng, Chun-Fai [1 ,2 ]
Leung, Ping-Chung [1 ,2 ]
Fung, Kwok-Pui [1 ,2 ,3 ]
Poon, Simon Kar-Sing [4 ]
Lau, Clara Bik-San [1 ,2 ]
机构
[1] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, State Key Lab Phytochem & Plant Resources W China, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China
[4] Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia
关键词
Salvia miltiorrhiza; Danshen; Pueraria lobata; Gegen; Herbal formula; Combination effect; Atherosclerosis; OXIDE SYNTHASE EXPRESSION; NITRIC-OXIDE; FOAM CELL; ACID-B; ATHEROSCLEROSIS; RAT; MECHANISMS; PROLIFERATION; CHOLESTEROL; MIGRATION;
D O I
10.1016/j.jep.2012.08.011
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) are principle herbs of Chinese herbal formulae which have long been used to treat cardiovascular diseases. Aim of study: The present study validated the anti-atherogenic effects of three extracts, Danshen alone (DE), Gegen alone (GE) as well as DGE and interpreted their combination effects statistically. Materials and methods: The anti-atherogenic effects of the three extracts were studied in three assays with regards to inflammation, foam cell formation and vascular smooth muscle cell (vSMC) proliferation using lipopolysaccharide (LPS)-induced nitric oxide production model, macrophage foam cell formation model and platelet-derived growth factor (PDGF)-induced vSMC proliferation model, respectively. The combination effects of DGE were statistically analyzed using combination index (Cl) and fixed-ratio experimental design. Results: The anti-atherogenic effects of the three extracts including anti-inflammation, anti-foam cell formation and anti-vSMC proliferation were demonstrated in this study. Their combination effects in anti-inflammation, anti-foam cell formation and anti-vSMC proliferation were found to be synergistic, additive and antagonistic, respectively. Conclusions: This study provided scientific support for the combination use of DGE on atherosclerosis and presented one of the first applications of statistical interpretations of the combination effects of the 2-herb formula. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:859 / 866
页数:8
相关论文
共 40 条
[1]   Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling:: new perspectives and therapeutic potential [J].
Andrés, V .
CARDIOVASCULAR RESEARCH, 2004, 63 (01) :11-21
[2]   Monocyte recruitment and foam cell formation in atherosclerosis [J].
Bobryshev, YV .
MICRON, 2006, 37 (03) :208-222
[3]   Anti-inflammatory therapeutics for the treatment of atherosclerosis [J].
Charo, Israel F. ;
Taub, Rebecca .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) :365-376
[4]   Inhibitory effects of lithospermic acid on proliferation and migration of rat vascular smooth muscle cells [J].
Chen, Li ;
Wang, Wen-yi ;
Wang, Yi-ping .
ACTA PHARMACOLOGICA SINICA, 2009, 30 (09) :1245-1252
[5]   Long-Term Treatment with Danshen-Gegen Decoction Protects the Myocardium against Ischemia/Reperfusion Injury via the Redox-Sensitive Protein Kinase C-ε/mKATP Pathway in Rats [J].
Chiu, Po Yee ;
Wong, Sze Man ;
Leung, Hoi Yan ;
Leong, Pou Kuan ;
Chen, Na ;
Zhou, Limin ;
Zuo, Zhong ;
Lam, Philip Y. ;
Ko, Kam Ming .
REJUVENATION RESEARCH, 2011, 14 (02) :173-184
[6]   Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora [J].
Choo, MK ;
Park, EK ;
Yoon, HK ;
Kim, DH .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (10) :1328-1332
[7]   Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method [J].
Chou, Ting-Chao .
CANCER RESEARCH, 2010, 70 (02) :440-446
[8]   Vascular inflammation as a therapeutic target for prevention of cardiovascular disease. [J].
Clark L.T. .
Current Atherosclerosis Reports, 2002, 4 (2) :77-81
[9]  
DONG ZT, 1982, ACTA PHARM SINICA, V17, P226
[10]  
Jang SI, 2003, PLANTA MED, V69, P1057, DOI 10.1055/s-2003-45157